Molina Healthcare, Inc. (MOH)
Fast Mover / Super Equity Analysis — November 17, 2025
Overview
Molina Healthcare (MOH) has emerged as both a Fast Mover and a Super Equity candidate within our cycle framework. The stock has undergone a significant multi-year decline and is now approaching a major cyclical bottom that is expected to unlock an exceptional long-term upside opportunity.
Time Analysis
Our cycle composite projects the primary bottom forming in March 2026.
Given the broader market’s projected trajectory, it is also plausible that MOH extends its low into Q4 2026, coinciding with the expected market-wide trough. Both windows remain in alignment with the long-term structural picture.
Price Analysis
The bottom projection for MOH is unusually clear:
-
Primary Bottom Target: $100 ± $15
-
Short-Term Monitoring Threshold: When price reaches ≈ $120, a refined targeting analysis will be required to lock in the exact entry zone.
Once the bottom is established, MOH is poised for a substantial multi-year expansion.
-
Primary Upside Target: $600 (long-term, into 2029)
-
Extended Target Zone: $725 (“dark green region”) — a high-probability secondary objective by the end of 2029.
This translates into a potential 5x–7x return from the projected bottoming area.
Strategic Outlook
MOH should be added to the high-priority accumulation watchlist.
As the stock approaches $120, we will conduct a precise bottom-target recalculation to tighten the $100 ± $15 range and define the optimal long entry.
Once the bottom is confirmed, the stock is expected to deliver strong, sustained appreciation throughout 2027–2029.
Conclusion
Molina Healthcare presents one of the most compelling setups within our current Fast Mover/Super Equity universe. A major cyclical low is imminent in the $85–$115 region, with long-term upside potential toward $600–$725 by 2029. A refined targeting update will be issued once the stock approaches $120, preparing for a decisive long entry into the next major cycle.
